Cefcanel daloxate
Cefcanel daloxate (KY-109 (free base) ) is an orally active cephalosporin prodrug against Gram-positive bacteria and Haemophilus influenzae. Cefcanel daloxate is promising for research of uremia[1].
Product Specifications
Product Name Alternative
KY-109 (free base)
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefcanel-daloxate.html
Smiles
O=C1OC(COC(C2=C(CSC3=NN=C(C)S3)CS[C@@]([C@@H]4NC([C@@H](C5=CC=CC=C5)OC([C@@H](N)C)=O)=O)([H])N2C4=O)=O)=C(C)O1
Molecular Formula
C27H27N5O9S3
Molecular Weight
661.73
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-129914/Cefcanel-daloxate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-129914/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[97275-40-6]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RIPPLY2 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
